Loading...

Cresco Labs Inc.

CRLBFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.68
$0.05(8.03%)

Cresco Labs Inc. (CRLBF) Stock Overview

Explore Cresco Labs Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap236.4M
P/E Ratio-2.92
EPS (TTM)$-0.24
ROE-0.18%
Fundamental Analysis

AI Price Forecasts

1 Week$0.50
1 Month$0.39
3 Months$0.96
1 Year Target$0.09

CRLBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cresco Labs Inc. (CRLBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.92 and a market capitalization of 236.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;